Skip to content

Clinical trials

Neuroblastoma trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Country / region: Sweden Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20051
20111
20131
20192
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting3
Unknown status2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Infant Neuroblastoma Study Group - 19994
Pfizer2
European Organisation for Research and Treatment of Cancer - EORTC1
Institut Curie1
Instituto de Investigacion Sanitaria La Fe1
Jakob Stenman1
Lund University Hospital1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Societe Internationale d'Oncologie Pediatrique1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma16
Burkitt Lymphoma2
Lymphoma, Large B-Cell, Diffuse2
Neoplasms2
Sarcoma, Ewing2
Astrocytoma1
Blast Crisis1
Bone Neoplasms1
Breast Neoplasms1
Carcinoma, Embryonal1

Trials

Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.